Tower Research Capital (TRC)’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
Tower Research Capital (TRC)'s MIRM Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Mirum Pharmaceuticals (MIRM) stake by 322% in Q3 2026, buying an estimated $778K and bringing the position to 9,772 shares worth $835K. The position accounts for 0.01% of the portfolio, ranked #1185.
Tower Research Capital (TRC) first reported a position in MIRM in Q3 2019 and has held it in 27 quarters since. 315 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- Tower Research Capital (TRC) held 9,772 shares of Mirum Pharmaceuticals worth $835K as of Q3 2026.
- Tower Research Capital (TRC) bought 7,454 Mirum Pharmaceuticals shares in Q3 2026, an estimated $778K.
- Mirum Pharmaceuticals made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #1185 holding.
- Tower Research Capital (TRC) first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 27 quarters since.
- 315 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.